methazolamide has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5% (48 mmol/mol) from 8 to 33%, a rapid reduction in alanine aminotransferase (∼10 units/L), and weight loss (2%) in metformin-cotreated patients." | 5.19 | Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study. ( Chambers, J; Krippner, G; MacGinley, R; Nicholson, GC; Orford, N; Phillips, G; Proietto, J; Sanders, KM; Sarah, A; Simpson, RW; Skoff, K; Wacher, VJ; Walder, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Li, Y | 1 |
| Yuan, X | 1 |
| Yuan, W | 1 |
| Li, C | 1 |
| Zeng, Y | 1 |
| Lian, Y | 1 |
| Qiu, X | 1 |
| Qin, Y | 1 |
| Zhang, G | 1 |
| Liu, X | 1 |
| Luo, C | 1 |
| Luo, JD | 1 |
| Hou, N | 1 |
| Simpson, RW | 1 |
| Nicholson, GC | 1 |
| Proietto, J | 1 |
| Sarah, A | 1 |
| Sanders, KM | 1 |
| Phillips, G | 1 |
| Chambers, J | 1 |
| MacGinley, R | 1 |
| Orford, N | 1 |
| Walder, K | 1 |
| Krippner, G | 1 |
| Skoff, K | 1 |
| Wacher, VJ | 1 |
1 trial available for methazolamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study.
Topics: Aged; Carbonic Anhydrase Inhibitors; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycate | 2014 |
1 other study available for methazolamide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Topics: Animals; Axin Protein; beta Catenin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dia | 2022 |